+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Over The Counter Drugs Market - Global Forecast 2026-2032- Product Image
Over The Counter Drugs Market - Global Forecast 2026-2032- Product Image
New

Over The Counter Drugs Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4807786
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The over-the-counter drugs market is in a phase of rapid transformation, driven by heightened consumer expectations, adaptive regulations, and integration of digital tools within healthcare. For senior decision-makers, understanding these trends is crucial to maintain organizational agility and unlock competitive advantages in a shifting landscape.

Market Snapshot: Over The Counter Drugs Market Size, Growth, and Outlook

The over-the-counter drugs market anticipates robust expansion, advancing from USD 56.75 billion in 2025 to USD 61.50 billion in 2026, with expectations to reach USD 103.96 billion by 2032, supported by a compound annual growth rate of 9.03%. Factors fueling this growth include an increasing emphasis on self-directed preventive care, rapid adoption of innovative product formulations, and evolving retail channels. These dynamics signal significant opportunity for pharmaceutical manufacturers and investors seeking to navigate a dynamic and expanding market.

Scope & Segmentation

  • Drug Categories: Cold, cough, and allergy medications; digestive aids; dermatological therapies; and pain relief products represent major segments, each shaped by changing consumer priorities and technological innovations.
  • Product Forms: Capsules, tablets, powders, liquids, topical preparations, sprays, suppositories, and gels provide options catering to patient preferences for convenience and targeted applications.
  • Distribution Channels: Pharmacies, drug stores, supermarkets, hypermarkets, and online retail platforms make over-the-counter drugs accessible, with digital-first strategies increasingly influencing buying behavior.
  • Age Groups: Adults, children, and seniors each require specialized dosing, packaging, and formulation, driving customized product development and marketing efforts.
  • End Users: Individual consumers, healthcare professionals, and institutional buyers have distinct product and delivery needs, requiring strategic supply chain and engagement approaches.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific exhibit varying levels of healthcare access, infrastructure, and regulatory compliance, making locally adapted strategies essential for market penetration.
  • Technology Adoption: The use of digital health platforms, advanced formulation technologies, and data analytics is streamlining product innovation and deepening consumer engagement.

Key Takeaways

  • Empowered consumers and a strong focus on preventive health are making over-the-counter drugs a vital part of daily wellness routines, increasing emphasis on self-care strategies.
  • Manufacturers are advancing innovation with clean-label, plant-based, and nonaddictive ingredients to align with consumer desire for transparency and sustainable products.
  • Regulatory bodies are optimizing approval pathways for lower-risk therapies, facilitating quicker introduction of new products and reducing time-to-market pressures.
  • Omnichannel retail expansion, including growth in e-commerce and digital health, is reshaping purchase behavior and enhancing distribution channel effectiveness.
  • Partnerships with biotechnology and retail companies are strengthening competitiveness and enabling faster adoption of proprietary products and solutions.
  • Variation in healthcare infrastructure and regulations by region underscores the need for targeted, market-specific strategies to sustain growth.

Tariff Impact on the Over The Counter Drugs Market

The implementation of United States tariffs in 2025 introduced complexities to the over-the-counter drugs market, most notably impacting supply chains and increasing production costs. Manufacturers are mitigating these effects through supplier diversification and investment in domestic production capabilities, with an emphasis on collaborative research and development. Distributors and retailers are adopting agile pricing strategies to maintain accessibility for consumers while managing changes across affected product lines.

Methodology & Data Sources

This report combines primary research—such as executive interviews in product formulation, manufacturing, and retail—with rigorous secondary research from top industry publications, regulatory filings, and academic sources. Data reliability is reinforced through expert triangulation and assessment, providing decision-ready insights.

Why This Report Matters

  • Empowers senior managers to optimize growth strategies and enhance product portfolios within the over-the-counter drugs market.
  • Enables supply chain leaders to anticipate and address risks by understanding the effects of tariffs, regulatory adjustments, and evolving supplier networks.
  • Equips decision-makers with region-specific intelligence to inform strategic entry, expansion, and partnership initiatives in a changing healthcare environment.

Conclusion

This analysis gives leaders a clear reference point for building resilient, forward-looking strategies in the over-the-counter drugs market. Leveraging these insights can enable agile decision-making and long-term value for organizations navigating ongoing change.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Over The Counter Drugs Market, by Drug Type
8.1. Cold, Cough, & Allergy Medications
8.1.1. Antihistamines
8.1.2. Cough Suppressants
8.1.3. Decongestants
8.2. Dermatology & Skin Care
8.2.1. Acne Treatments
8.2.2. Antifungal Creams
8.2.3. Skin Protectants
8.3. Digestive Health
8.3.1. Antacids
8.3.2. Anti-diarrheal
8.3.3. Laxatives
8.4. Eye & Ear Care
8.5. Pain Relief Medications
8.6. Vitamins & Supplements
9. Over The Counter Drugs Market, by Product Form
9.1. Capsules
9.2. Liquids/Syrups
9.3. Powders
9.4. Sprays
9.5. Suppositories
9.6. Tablets/Pills
9.7. Topical Creams/Ointments/Gels
10. Over The Counter Drugs Market, by Distribution Channel
10.1. Offline
10.1.1. Pharmacies & Drug Stores
10.1.2. Supermarkets & Hypermarkets
10.2. Online
11. Over The Counter Drugs Market, by Age Group
11.1. Adult
11.2. Geriatric
11.3. Pediatric
12. Over The Counter Drugs Market, by End-user
12.1. Healthcare Professionals
12.2. Individual Consumers
12.3. Institutional Users
13. Over The Counter Drugs Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Over The Counter Drugs Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Over The Counter Drugs Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Over The Counter Drugs Market
17. China Over The Counter Drugs Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Amneal Pharmaceuticals LLC
18.6. Aurobindo Pharma Limited
18.7. Bayer AG
18.8. Cipla Limited
18.9. Dr. Reddy’s Laboratories Inc.
18.10. Genomma group
18.11. GSK plc
18.12. Hisamitsu Pharmaceutical Co., Inc.
18.13. Johnson & Johnson Services, Inc.
18.14. LNK International, Inc.
18.15. Novartis AG
18.16. Perrigo Company plc
18.17. Pfizer Inc.
18.18. Pierre Fabre S.A
18.19. PL Developments LLC
18.20. Procter & Gamble Manufacturing Company
18.21. Reckitt Benckiser LLC
18.22. Sanofi S.A.
18.23. Sun Pharmaceutical Industries Limited
18.24. Taisho Pharmaceutical Co., Ltd.
18.25. Teva Pharmaceutical Industries Ltd
18.26. The Mentholatum Company, Inc.
18.27. Tris Pharma, Inc.
18.28. Viatris Inc.
18.29. Wörwag Pharma GmbH & Co. KG
18.30. Zentiva Group, a.s.
List of Figures
FIGURE 1. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL OVER THE COUNTER DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL OVER THE COUNTER DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH SUPPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH SUPPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH SUPPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DECONGESTANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DECONGESTANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DECONGESTANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ACNE TREATMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ACNE TREATMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ACNE TREATMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTIFUNGAL CREAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTIFUNGAL CREAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTIFUNGAL CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SKIN PROTECTANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SKIN PROTECTANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SKIN PROTECTANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTACIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTI-DIARRHEAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTI-DIARRHEAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTI-DIARRHEAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY LAXATIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY LAXATIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY EYE & EAR CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY EYE & EAR CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY EYE & EAR CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PAIN RELIEF MEDICATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PAIN RELIEF MEDICATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PAIN RELIEF MEDICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS & SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS & SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS & SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY LIQUIDS/SYRUPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY LIQUIDS/SYRUPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY LIQUIDS/SYRUPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY POWDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY POWDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SPRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SPRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SPRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SUPPOSITORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SUPPOSITORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY TABLETS/PILLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY TABLETS/PILLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY TABLETS/PILLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY TOPICAL CREAMS/OINTMENTS/GELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY TOPICAL CREAMS/OINTMENTS/GELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY TOPICAL CREAMS/OINTMENTS/GELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PHARMACIES & DRUG STORES, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PHARMACIES & DRUG STORES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PHARMACIES & DRUG STORES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HEALTHCARE PROFESSIONALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HEALTHCARE PROFESSIONALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HEALTHCARE PROFESSIONALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY INDIVIDUAL CONSUMERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY INDIVIDUAL CONSUMERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY INDIVIDUAL CONSUMERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY INSTITUTIONAL USERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY INSTITUTIONAL USERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY INSTITUTIONAL USERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 148. EUROPE OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. EUROPE OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPE OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 151. EUROPE OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 153. EUROPE OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 154. EUROPE OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. EUROPE OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 156. EUROPE OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 157. EUROPE OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 168. AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 170. AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 171. AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 172. AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 173. AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 174. AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 175. AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 176. AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 177. AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. ASEAN OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. ASEAN OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASEAN OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 192. ASEAN OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 193. ASEAN OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 194. ASEAN OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 195. ASEAN OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. ASEAN OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 197. ASEAN OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 198. ASEAN OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 199. GCC OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. GCC OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 201. GCC OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 202. GCC OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 203. GCC OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 204. GCC OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 205. GCC OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 206. GCC OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 207. GCC OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 208. GCC OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 219. BRICS OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. BRICS OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 221. BRICS OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 222. BRICS OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 223. BRICS OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 224. BRICS OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 225. BRICS OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 226. BRICS OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 227. BRICS OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 228. BRICS OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 229. G7 OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. G7 OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 231. G7 OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 232. G7 OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 233. G7 OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 234. G7 OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 235. G7 OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 236. G7 OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 237. G7 OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 238. G7 OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 239. NATO OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. NATO OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 241. NATO OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 242. NATO OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 243. NATO OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 244. NATO OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 245. NATO OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. NATO OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 247. NATO OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 248. NATO OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 252. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 254. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 255. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 257. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 258. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 260. CHINA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 261. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 262. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 263. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2032 (USD MILLION)
TABLE 264. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 265. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
TABLE 266. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 267. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 268. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 269. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Over The Counter Drugs market report include:
  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma Limited
  • Bayer AG
  • Cipla Limited
  • Dr. Reddy’s Laboratories Inc.
  • Genomma group
  • GSK plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson Services, Inc.
  • LNK International, Inc.
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Pierre Fabre S.A
  • PL Developments LLC
  • Procter & Gamble Manufacturing Company
  • Reckitt Benckiser LLC
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Taisho Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd
  • The Mentholatum Company, Inc.
  • Tris Pharma, Inc.
  • Viatris Inc.
  • Wörwag Pharma GmbH & Co. KG
  • Zentiva Group, a.s.

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 61.5 Billion
Forecasted Market Value ( USD ) by 2032 $ 103.96 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

United States Over-The-Counter Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

United States Over-The-Counter Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 100 Pages
  • United States
From
North America OTC Health Products Market Size, Share & Trends Analysis By Application (Digestive Health, Women's Health), Form (Liquid, Gummies), Product, Demography, Distribution Channel, and Segment Forecasts, 2025-2030 - Product Image

North America OTC Health Products Market Size, Share & Trends Analysis By Application (Digestive Health, Women's Health), Form (Liquid, Gummies), Product, Demography, Distribution Channel, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • North America
From
Over the Counter (OTC) Drugs - Global Strategic Business Report - Product Image

Over the Counter (OTC) Drugs - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Over the Counter (OTC) Drugs Market Report 2025 - Product Image

Over the Counter (OTC) Drugs Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Over the Counter (OTC) Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Over the Counter (OTC) Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 150 Pages
  • Global
From

About the Over the Counter (OTC) Drugs Market

The Over the Counter (OTC) Drugs market is a segment of the pharmaceutical industry that includes drugs that can be purchased without a prescription. These drugs are typically used to treat minor ailments such as headaches, colds, and allergies. OTC drugs are generally considered safe and effective when used as directed. OTC drugs are regulated by the Food and Drug Administration (FDA) and must meet certain safety and efficacy standards. The FDA also requires that OTC drugs be labeled with clear instructions for use. Some of the major players in the OTC Drugs market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Bayer, and Novartis. These companies produce a wide range of OTC drugs, including pain relievers, cold and flu remedies, antacids, and allergy medications. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.